J
JAGX
Jaguar Health Inc
2.910
-0.560-16.14%After Hours: 3.160 +0.250 +8.59%19:59 05/22 EDT
OPEN/PREV CLOSE2.980/3.190
TODAY RANGE2.970-3.300
VOL59.42K
MARKET CAP1.93M
52 WEEK RANGE2.530-171.50
AVG VOL (3M)62.76K
% TURNOVER9.85%
TURNOVER--
P/E (TTM)-0.0040
% RANGE10.34%
EPS(TTM)-803.9466
P/E(FORWARD)-0.7619
P/B-0.0369
BVPS-86.7356
DIVIDEND--
P/S0.0554
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.83M
SHARES OUTSTANDING603.13K
NEXT EARNINGS08/12-08/17
FREE FLOAT572.97K
LOT SIZE1
EX-DATE04/30/2026
News
Press Releases
Financial Reports
Profile
TipRanks·1d ago
Jaguar Health regains compliance with Nasdaq Listing Rule
TipRanks·1d ago
Jaguar Health Regains Nasdaq Bid Price Compliance Status
Seeking Alpha·05/21 14:40
Jaguar Health GAAP EPS of -$13.60, revenue of $20.27M
Benzinga·05/21 12:06
12 Health Care Stocks Moving In Thursday's Pre-Market Session
NASDAQ·05/21 09:50
Jaguar Health Reports Q1 2026 Revenue Surge Driven By Licensing Deal
TipRanks·05/20 20:50
Jaguar Health reports Q1 EPS ($13.60) vs. ($584.45) last year
Reuters·05/20 20:40
JAGUAR HEALTH INC - Q1 NET REVENUE $20.3 MLN- SEC FILING
PUBT·05/20 13:02
Jaguar Health publishes financial calendar update
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.